Filtravate
PrivateLast Round
Grant
Jan 2, 2024
Total Funding Raised
$956,000
Company Overview
Filtravate operates in Healthcare & Life Sciences and is based in Las Cruces, New Mexico. Its latest recorded funding round was a Grant round in January 2024.
Filtravate is a biotechnology company that develops and commercializes advanced ultrafiltration membranes for use in bioprocessing and biopharmaceutical manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Filtravate Comparables
Compare Filtravate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Danaher | 74% | |
| Meissner | 73% | |
| Asahi Kasei | 71% |
For institutional investors. Book with your work email.
Filtravate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 2, 2024 | ||||
| Grant | Sep 19, 2022 | ||||
| Angel | Feb 14, 2022 | ||||
| Seed | Feb 26, 2020 |
For institutional investors. Book with your work email.
Filtravate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VIC Investor Network | Seed |
| Department of Energy | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2024
$400K grant from Department of Energy and NM program.
- Feb 14, 2022
$300K raised in an angel round.
For institutional investors. Book with your work email.
Filtravate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Filtravate's valuation, stock price, and market status.
Is Filtravate a public or private company?
Filtravate is a private company.
What is the current stock price of Filtravate?
Filtravate is a private company, so its shares have no public market price. Caplight tracks Filtravate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Filtravate worth (valuation)?
Valuation information for Filtravate is not publicly available.
Can I buy Filtravate stock?
Filtravate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Filtravate's last funding round?
Filtravate's most recent funding round was Grant on January 2, 2024.
Who are the main investors in Filtravate?
Key investors in Filtravate include VIC Investor Network, Department of Energy, National Science Foundation.
Will Filtravate IPO soon?
No public IPO plans have been announced for Filtravate.
How can I track Filtravate secondary market activity?
Caplight tracks bids, offers, and trades in Filtravate's shares on secondary markets.